2002, Number 4
<< Back Next >>
Rev Mex Pediatr 2002; 69 (4)
Electrocardiographic evaluation of children receiving cisapride
Alonso AR, Loranca CS, Pérez BF, Gómez LJA, Castrejón RG, Flores AA
Language: Spanish
References: 13
Page: 129-132
PDF size: 45.20 Kb.
ABSTRACT
Objective. To confirm if the therapeutical dose of cisapride in children with gastroesophagical reflux, are associated to electrocardiographic alterations.
Material and methods. Forty children were evaluated by electrocardiographic studies; all of them were below one year of age and suffered reflux. They received cisapride during 60 days, doses of 0.2 mg/kg every 8 hours. The electrocardiograms were taken at the begin of treatment and 60 days after. Results. The rhythm and the heart frequency as well as the electrocardiographic reports were normal: the wave P, the segment PR, the complex QRS, the axis QRS and the segment QT, were inside the range of normality for the age of the children and the heart frequency (for the segment QT).
Conclusions. Findings seem to justify the employment of this medication in cases of gastroesophagic reflux, if the recommendations of the pediatric gastroenterologic societies of Europe and the United States of America are respected.
REFERENCES
Beltrán BF. El reflujo gastroesofágico en los niños, fisiopatología, clínica, diagnóstico y tratamiento. Rev Mex Pediatr 1999; 68.
Janssen Pharmaceutic suspende la venta de cisaprida. Pan Am J Public Health 2000; 7: 178.
Fabian W. Gastroesophageal reflux in infants and children. Mayo Clinic Preceding 1998; 73: 166-73.
Von Eygen. Effected of cisapride on excessive regurgitation in infants. Clin Pharmacy There 1989; 11: 669-72.
Cuchira. Effect of cisapride on parameters of esophageal motility prolog intraesphogea pH test infants with gastroesophagus. Disease Gut 1990; 31: 21-5.
Attie F, Zaval A, Buendía S. Cardiología pediátrica. México: Panamericana, 1995: capítulo 55.
Liebman J, Plonsey R. Pediatric electrocardiography. Baltimore: Williams and Wilkins 1982: 1-39.
Santamaría H. El electrocardiograma del recién nacido prematuro sano. Arch Inst Cardiol Mex 1991; 61: 539-47.
Benatar A. Effects of cisapride on corrected QT interval heart rate and rhythm in infants undergoing polysomnography. Pediatric 2000; 106: 85e.
Ramírez-Mayan J. Cisapride and QT interval in children. Pediatric 2000; 106: 1028-30.
Hasmi D. Prospective evaluation of cisapride on corrected QT interval in infant. Cardiology in young 2001; 2: supl I, (may).
Vandenplas. Current pediatric indications for cisapride report: a position paper by a panel coned by the European Society for Pediatric Gastroenterology, Hematology and Nutrition. Academic Children’s Hospital, Free Univ of Brussels, 2000.
Shulman R. An update medical position statement of North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol 2000; 31: 232-33.
Full text